醫療推進劑的全球市場:類型·用途·終端用戶 (醫療設備製造商·CMO·研究實驗室)·不同地區的預測 (～2032年)

全球醫用推進劑市場規模預計將從2023年的2.7億美元成長到2024年的3億美元，預測期內複合年增長率為10.16%，到2032年將達到7.2億美元。增長至 10,000,000 美元。

醫用推進劑市場可能會受到呼吸系統疾病盛行率上升的重大影響，包括慢性阻塞性肺病 (COPD) 和氣喘。其影響是對使用推進劑的吸入療法和設備的需求增加。呼吸系統疾病的流行增加了對吸入器的需求，這是我正在使用的將藥物輸送到肺部的重要設備。

區域展望

2023年，北美地區佔據最大的市場佔有率。就成長率而言，歐洲預計在預測期內也將呈現最高的複合年增長率。

在支持性的監管環境、技術進步和不斷增長的醫療保健要求的推動下，北美市場的特點是強勁增長。此外，對研發和先進醫療基礎設施的大量投資促進了尖端醫療推進劑的開發，並引領了該地區的市場。

歐洲醫用推進劑市場的特點是推進劑配方的開發取得了進展。歐洲製藥業成熟，擁有強大的分銷管道、合作夥伴關係並遵守嚴格的歐洲法規。因此，我們的產品符合安全性和有效性的高標準，贏得了消費者的信任。人口老化導致呼吸系統疾病盛行率增加，進一步加劇了對高品質吸入器的需求。

由於各種關鍵因素，預計亞太地區在預測期內也將呈現強勁成長。中國、印度和日本等國家醫療保健基礎設施的快速擴張和醫療保健基礎設施投資的增加推動了對使用醫用推進劑的高性能吸入器的需求。

本報告提供全球醫療推進劑的市場調查，彙整市場定義和概要，市場成長的各種影響因素分析，市場規模的轉變·預測，各種區分·地區/各主要國家的明細，競爭環境，主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 市場概要

第3章 調查手法

第4章 市場動態

• 促進因素
  • 氣喘和慢性阻塞性肺病等呼吸系統疾病的發生率增加
  • 吸入器的技術進步
  • 提高預防保健意識
• 阻礙因素
  • 先進推進劑成本高昂
• 機會
  • 新興市場

第5章 市場要素分析

• 波特的五力分析
• COVID-19對全球醫療推進劑市場帶來的影響

第6章 全球醫療推進劑市場:各類型

• 概要
• HFA 134A
• HFA 227EA
• HFA 152A

第7章 全球醫療推進劑市場:各用途

• 概要
• 發表會定量吸入器
• 呼吸工作式定量吸入器

第8章 全球醫療推進劑市場:各終端用戶

• 概要
• 醫療設備企業
• CMO
• 研究實驗室

第9章 全球醫療推進劑市場:各地區

• 概要
• 北美
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 其他
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 其他
• 其他地區
  • 中東·非洲
  • 南美

第10章 競爭情形

• 市場佔有率分析
• 競爭儀表板
• 上市公司的股票概要
• 比較分析:主要企業的財務
• 主要的展開·成長策略

第11章 企業簡介

• KOURA
• SRF
• DAIKIN CHEMICAL EUROPE GMBH
• LINDE PLC
• XIAMEN JUDA CHEMICAL & EQUIPMENT CO., LTD
• JIANGSU JULY CHEMICAL CO., LTD.
• BEIJING YUJI TECHNOLOGY DEVELOPMENT CO., LTD.
• ZHEJIANG JUSHEN NEW MATERIAL TECHNOLOGY CO., LTD.
• ZHEJIANG FOTECH INTERNATIONAL CO., LTD
• CHANGSHU 3F FLUOROCHEMICAL INDUSTRY CO., LTD.

第12章 資料的引用

Global Medical Propellants Market Research Report Information by Type (HFA 134A, HFA 227EA, HFA152A), By Application (Press Metered Dose Inhalers, Breath Actuated Metered Dose Inhalers), By End User (Medical Device Companies, Contract Manufacturing Organization (CMO), and Research Laboratories) And by Region (North America, Europe, Asia-Pacific, And Rest Of The World) Forecast Till 2032

Market Overview

In 2023, the Medical Propellants Market was estimated to be worth USD 0.27 billion. The industry is anticipated to experience a compound annual growth rate (CAGR) of 10.16% from USD 0.30 billion in 2024 to USD 0.72 billion by 2032 during the forecast period (2024-2032). The global metered-dose inhaler market is experiencing growth due to the increasing prevalence of respiratory conditions, including chronic obstructive pulmonary disease and asthma, as well as technological innovation in inhalation devices.

There is a significant likelihood that the medical propellants market will be significantly affected by the rising prevalence of respiratory disorders, including chronic obstructive pulmonary disease (COPD) and asthma. This effect is primarily the result of an increase in the demand for inhalation-based remedies and devices that utilize propellants. The demand for inhalers, which are essential devices for delivering medication to the lungs, is on the rise as respiratory maladies become more prevalent. These inhalers employ propellants to ensure that the medication is delivered effectively.

Market segment insights

The Medical Propellants Market has been segmented into HFA 134A, HFA 227EA, and HFA-152A based on type.

The Market has been segmented into manual metered dose inhalers and breath metered dose inhalers based on application.

According to the end user, the market has been divided into three categories: medical device companies, contract manufacturing organizations (CMOs), and research laboratories.

Regional Perspectives

In 2023, the market share that North America possessed was the most significant. Nevertheless, Europe is anticipated to experience the most significant compound annual growth rate (CAGR) during the 2024-2032 forecast period.

Robust growth is the hallmark of the Medical Propellants market in North America, which is driven by a supportive regulatory environment, technological advancements, and increased healthcare requirements. Additionally, the market is driven by the development of state-of-the-art Medical Propellants, which is made possible by a substantial investment in research and development and a sophisticated healthcare infrastructure.

Europe, which is further divided into Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe, follows the Americas region. The Medical Propellants market in Europe is characterized by the ongoing development of propellant formulations. The pharmaceutical sector in Europe is mature, which guarantees a strong distribution channel, collaborations, and adherence to stringent European regulations. This ensures that the products meet high safety and efficacy standards, which instills confidence in consumers. The demand for sophisticated, high-quality inhalers is further exacerbated by the aging population, which is driving the rise in the prevalence of respiratory diseases.

Over the forecast period, the Asia-Pacific region is anticipated to experience robust development, which is driven by a variety of key factors. It is also projected to be the fastest-growing region. The demand for sophisticated inhalers that utilize medical propellants is being driven by the rapid expansion of healthcare infrastructure and the increasing investments in healthcare infrastructure in countries such as China, India, and Japan.

Major Players

Koura (US), SRF (India), DAIKIN (Japan), Linde PLC (UK), Xiamen Juda Chemical & Equipment Co., Ltd. (China), Jiangsu July Chemical Co., Ltd. (China), Beijing Yuji Technology Development Co., Ltd. (China), Zhejiang Jushen New Material Technology Co., Ltd. (China), Zhejiang fotech international co., ltd. (China), and Changshu 3F Fluorochemical Industry Co., Ltd. (China) are among the key companies in the Medical Propellants Market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION

A propellant is a substance used to propel a medication from an aerosol canister or inhaler. These propellants are typically gases that help deliver medication in a fine mist or spray to ensure it can be effectively inhaled or applied.

• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 Data Mining Process
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 Secondary Research data flow:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 Primary Research DATA FLOW:
• 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1 Revenue Analysis Approach
• 3.7 DATA FORECASTING
  • 3.7.1 Data forecasting Type
• 3.8 DATA MODELING
  • 3.8.1 microeconomic factor analysis:
  • 3.8.2 Data modeling:
• 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 Rising incidence of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD)
  • 4.2.2 Technological Advancements in Inhalation Devices
  • 4.2.3 Increased awareness about preventive healthcare
• 4.3 RESTRAINTS
  • 4.3.1 High costs of advanced propellants
• 4.4 OPPORTUNITY
  • 4.4.1 Emerging markets offer significant growth opportunities

5 MARKET FACTOR ANALYSIS

• 5.1 PORTER'S FIVE FORCES MODEL
  • 5.1.1 Threat of New Entrants
  • 5.1.2 BARGAINING POWER OF SUPPLIERS
  • 5.1.3 Threat of Substitutes
  • 5.1.4 Bargaining Power of Buyers
  • 5.1.5 Intensity of Rivalry
• 5.2 IMPACT OF COVID-19 ON THE GLOBAL MEDICAL PROPELLANTS MARKET

6 GLOBAL MEDICAL PROPELLANTS MARKET, BY TYPE

• 6.1 OVERVIEW
• 6.2 HFA 134A
• 6.3 HFA 227EA
• 6.4 HFA-152A

7 GLOBAL MEDICAL PROPELLANTS MARKET, BY APPLICATION

• 7.1 OVERVIEW
• 7.2 PRESS METERED DOSE INHALERS
• 7.3 BREATH ACTUATED METERED DOSE INHALERS

8 GLOBAL MEDICAL PROPELLANTS MARKET, BY END USER

• 8.1 OVERVIEW
• 8.2 MEDICAL DEVICE COMPANIES
• 8.3 CONTRACT MANUFACTURING ORGANIZATION (CMO)
• 8.4 RESEARCH LABORATORIES

9 GLOBAL MEDICAL PROPELLANTS MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 NORTH AMERICA
  • 9.2.1 us
  • 9.2.2 canada
• 9.3 EUROPE
  • 9.3.1 Germany
  • 9.3.2 France
  • 9.3.3 UK
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 ASIA-PACIFIC
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia-Pacific
• 9.5 REST OF THE WORLD
  • 9.5.1 middle east & africa
  • 9.5.2 south america

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 MARKET SHARE ANALYSIS,
• 10.3 COMPETITOR DASHBOARD
• 10.4 PUBLIC PLAYERS STOCK SUMMARY
• 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
• 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.6.1 Facility expansion

11 COMPANY PROFILES

• 11.1 KOURA
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 products OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 SWOT ANALYSIS
  • 11.1.6 KEY STRATEGIES
• 11.2 SRF
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 Product OFFERed
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 KEY STRATEGIES
• 11.3 DAIKIN CHEMICAL EUROPE GMBH
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 productS OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 KEY STRATEGIES
• 11.4 LINDE PLC
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 productS OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 SWOT ANALYSIS
  • 11.4.6 KEY STRATEGIES
• 11.5 XIAMEN JUDA CHEMICAL & EQUIPMENT CO., LTD
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 SWOT ANALYSIS
  • 11.5.6 KEY STRATEGIES
• 11.6 JIANGSU JULY CHEMICAL CO., LTD.
  • 11.6.1 COMPANY OVERVIEw
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 Product OFFERed
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 KEY STRATEGIES
• 11.7 BEIJING YUJI TECHNOLOGY DEVELOPMENT CO., LTD.
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 SWOT ANALYSIS
  • 11.7.6 KEY STRATEGIES
• 11.8 ZHEJIANG JUSHEN NEW MATERIAL TECHNOLOGY CO., LTD.
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 Product OFFERed
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 KEY STRATEGIES
• 11.9 ZHEJIANG FOTECH INTERNATIONAL CO., LTD
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 Product OFFERed
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 SWOT ANALYSIS
  • 11.9.6 KEY STRATEGIES
• 11.10 CHANGSHU 3F FLUOROCHEMICAL INDUSTRY CO., LTD.
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 Product OFFERed
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 KEY STRATEGIES

12 DATA CITATIONS

LIST OF TABLES

• TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
• TABLE 2 GLOBAL MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 3 GLOBAL MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 4 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA 134A, BY REGION, 2019-2032 (USD MILLION)
• TABLE 5 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA 134A, BY REGION, 2019-2032 (METRIC TON)
• TABLE 6 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA 227EA, BY REGION, 2019-2032 (USD MILLION)
• TABLE 7 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA 227EA, BY REGION, 2019-2032 (METRIC TON)
• TABLE 8 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA-152A, BY REGION, 2019-2032 (USD MILLION)
• TABLE 9 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA-152A, BY REGION, 2019-2032 (METRIC TON)
• TABLE 10 GLOBAL MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 11 GLOBAL MEDICAL PROPELLANTS MARKET, FOR PRESS METERED DOSE INHALERS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 12 GLOBAL MEDICAL PROPELLANTS MARKET, FOR BREATH ACTUATED METERED DOSE INHALERS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 13 GLOBAL MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 14 GLOBAL MEDICAL PROPELLANTS MARKET, FOR MEDICAL DEVICE COMPANIES, BY REGION, 2019-2032 (USD MILLION)
• TABLE 15 GLOBAL MEDICAL PROPELLANTS MARKET, FOR CONTRACT MANUFACTURING ORGANIZATION (CMO), BY REGION, 2019-2032 (USD MILLION)
• TABLE 16 GLOBAL MEDICAL PROPELLANTS MARKET, FOR RESEARCH LABORATORIES, BY REGION, 2019-2032 (USD MILLION)
• TABLE 17 GLOBAL MEDICAL PROPELLANTS MARKET, BY REGION, 2019-2032 (USD MILLION)
• TABLE 18 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 19 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 20 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 21 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 22 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 23 US: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 24 US: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 25 US: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 26 US: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 27 CANADA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 28 CANADA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 29 CANADA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 30 CANADA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 31 EUROPE: MEDICAL PROPELLANTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 32 EUROPE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 33 EUROPE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 34 EUROPE: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 35 EUROPE: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 36 GERMANY: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 37 GERMANY: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 38 GERMANY: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 39 GERMANY: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 40 FRANCE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 41 FRANCE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 42 FRANCE: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 43 FRANCE: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 44 UK: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 45 UK: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 46 UK: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 47 UK: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 48 ITALY MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 49 ITALY MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 50 ITALY MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 51 ITALY: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 52 SPAIN: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 53 SPAIN: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 54 SPAIN: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 55 SPAIN: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 56 REST OF EUROPE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 57 REST OF EUROPE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 58 REST OF EUROPE: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 59 REST OF EUROPE: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 60 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 61 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 62 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 63 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 64 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 65 CHINA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 66 CHINA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 67 CHINA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 68 CHINA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 69 INDIA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 70 INDIA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 71 INDIA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 72 INDIA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 73 JAPAN: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 74 JAPAN: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 75 JAPAN: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 76 JAPAN: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 77 AUSTRALIA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 78 AUSTRALIA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 79 AUSTRALIA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 80 AUSTRALIA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 81 SOUTH KOREA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 82 SOUTH KOREA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 83 SOUTH KOREA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 84 SOUTH KOREA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 85 REST OF ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 86 REST OF ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 87 REST OF ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 88 REST OF ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 89 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 90 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 91 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 92 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 93 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 94 MIDDLE EAST & AFRICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 95 MIDDLE EAST & AFRICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 96 MIDDLE EAST & AFRICA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 97 MIDDLE EAST & AFRICA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 98 SOUTH AMERICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 99 SOUTH AMERICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 100 SOUTH AMERICA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 101 SOUTH AMERICA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 102 FACILITY EXPANSION
• TABLE 103 KOURA: PRODUCT OFFERED
• TABLE 104 KOURA: KEY DEVELOPMENT
• TABLE 105 SRF: PRODUCTS OFFERED
• TABLE 106 DAIKIN CHEMICAL EUROPE GMBH: PRODUCT OFFERED
• TABLE 107 LINDE PLC: PRODUCT OFFERED
• TABLE 108 XIAMEN JUDA CHEMICAL & EQUIPMENT CO., LTD: PRODUCTS OFFERED
• TABLE 109 JIANGSU JULY CHEMICAL CO., LTD.: PRODUCTS OFFERED
• TABLE 110 BEIJING YUJI TECHNOLOGY DEVELOPMENT CO., LTD.: PRODUCTS OFFERED
• TABLE 111 ZHEJIANG JUSHEN NEW MATERIAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
• TABLE 112 ZHEJIANG FOTECH INTERNATIONAL CO., LTD.: PRODUCTS OFFERED
• TABLE 113 CHANGSHU 3F FLUOROCHEMICAL INDUSTRY CO., LTD.: PRODUCTS OFFERED

LIST OF FIGURES

• FIGURE 1 GLOBAL MEDICAL PROPELLANTS MARKET: STRUCTURE
• FIGURE 2 GLOBAL MEDICAL PROPELLANTS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
• FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
• FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
• FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL MEDICAL PROPELLANTS MARKET
• FIGURE 6 GLOBAL MEDICAL PROPELLANTS MARKET, TYPE, 2023 & 2032 (USD MILLION)
• FIGURE 7 GLOBAL MEDICAL PROPELLANTS MARKET, BY TYPE, 2023 & 2032 (USD MILLION)
• FIGURE 8 GLOBAL MEDICAL PROPELLANTS MARKET SHARE (%), BY TYPE,
• FIGURE 9 GLOBAL MEDICAL PROPELLANTS MARKET, APPLICATION, 2023 & 2032 (USD MILLION)
• FIGURE 10 GLOBAL MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
• FIGURE 11 GLOBAL MEDICAL PROPELLANTS MARKET SHARE (%), BY APPLICATION,
• FIGURE 12 GLOBAL MEDICAL PROPELLANTS MARKET, END USER, 2023 & 2032 (USD MILLION)
• FIGURE 13 GLOBAL MEDICAL PROPELLANTS MARKET, BY END USER, 2023 & 2032 (USD MILLION)
• FIGURE 14 GLOBAL MEDICAL PROPELLANTS MARKET SHARE (%), BY END USER,
• FIGURE 15 GLOBAL MEDICAL PROPELLANTS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
• FIGURE 16 GLOBAL MEDICAL PROPELLANTS MARKET SHARE, BY REGION, 2023 (% SHARE)
• FIGURE 17 NORTH AMERICA MARKET ANALYSIS: MEDICAL PROPELLANTS MARKET, 2019-2032 (USD MILLION)
• FIGURE 18 NORTH AMERICA MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
• FIGURE 19 NORTH AMERICA MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 (%)
• FIGURE 20 EUROPE MARKET ANALYSIS: MEDICAL PROPELLANTS MARKET, 2019-2032 (USD MILLION)
• FIGURE 21 EUROPE MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
• FIGURE 22 EUROPE MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 (%)
• FIGURE 23 ASIA-PACIFIC MARKET ANALYSIS: MEDICAL PROPELLANTS MARKET, 2019-2032 (USD MILLION)
• FIGURE 24 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
• FIGURE 25 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 (%)
• FIGURE 26 REST OF THE WORLD: MARKET ANALYSIS: MEDICAL PROPELLANTS MARKET, 2019-2032 (USD MILLION)
• FIGURE 27 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
• FIGURE 28 REST OF THE WORLD MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 (%)
• FIGURE 29 GLOBAL MEDICAL PROPELLANTS MARKET PLAYERS: COMPETITIVE ANALYSIS,
• FIGURE 30 COMPETITOR DASHBOARD: GLOBAL MEDICAL PROPELLANTS MARKET
• FIGURE 31 KOURA: SWOT ANALYSIS
• FIGURE 32 SRF: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 33 LINDE PLC SWOT ANALYSIS
• FIGURE 34 XIAMEN JUDA CHEMICAL & EQUIPMENT CO., LTD: SWOT ANALYSIS
• FIGURE 35 BEIJING YUJI TECHNOLOGY DEVELOPMENT CO., LTD.: SWOT ANALYSIS
• FIGURE 36 ZHEJIANG FOTECH INTERNATIONAL CO., LTD.: SWOT ANALYSIS